Search Results
Aug 05, 2026, 13:46 ET S&T Bancorp, Inc. Declares Dividend
INDIANA, Pa., Aug. 5, 2026 /PRNewswire/ -- The board of directors of S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, approved a $0.37 per share cash dividend on August 5, 2026. This is an increase of $0.03, or 8.82 percent, compared
More news about: S&T Bancorp, Inc.
Jul 23, 2026, 07:30 ET S&T Bancorp, Inc. Announces Second Quarter 2026 Results
INDIANA, Pa., July 23, 2026 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced net income of $36.6 million for the second quarter of 2026 compared to $35.1 million for the first
More news about: S&T Bancorp, Inc.
Jul 23, 2026, 07:25 ET S&T Bancorp, Inc. Announces $100 Million Share Repurchase Program
INDIANA, Pa., July 23, 2026 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced that the board of directors authorized a new $100 million share repurchase program at its meeting held
More news about: S&T Bancorp, Inc.
Jul 01, 2026, 09:26 ET S&T Bancorp, Inc. to Host Second Quarter Earnings Conference Call and Webcast
INDIANA, Pa., July 1, 2026 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced today that a conference call detailing the company's second quarter earnings will be held live via
More news about: S&T Bancorp, Inc.
Jun 18, 2026, 08:35 ET S&T BANK RAISES RECORD $120,000 FOR CHILDHOOD CANCER RESEARCH
Pa., June 18, 2026 /PRNewswire/ -- S&T Bank, the wholly owned subsidiary of S&T Bancorp Inc. (NASDAQ, STBA), today announced a record-breaking $120,000 donation to Alex's Lemonade Stand Foundation (ALSF) in 2026, exceeding its $85,000 goal. Now in its fourth
More news about: S&T Bank
Jun 17, 2026, 12:19 ET S&T BANK NAMED A FORBES AMERICA'S BEST-IN-STATE BANK FOR 2026
June 17, 2026 /PRNewswire/ -- S&T Bank, the wholly owned subsidiary of S&T Bancorp, Inc. (NASDAQ: STBA), has been named to the
More news about: S&T Bank
Apr 29, 2026, 15:51 ET S&T Bancorp, Inc. Increases Quarterly Cash Dividend
Pa., April 29, 2026 /PRNewswire/ -- The Board of Directors of S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, approved a $0.37 per share cash dividend on April 29, 2026. This is an increase of $0.01, or 2.78 percent, compared
More news about: S&T Bancorp, Inc.
Apr 23, 2026, 07:30 ET S&T Bancorp, Inc. Announces First Quarter 2026 Results
INDIANA, Pa., April 23, 2026 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced net income of $35.1 million for the first quarter of 2026 compared to $34.0 million for the fourth
More news about: S&T Bancorp, Inc.
Apr 21, 2026, 08:00 ET Celltrion to present seven abstracts in inflammatory bowel disease (IBD) at 2026 Digestive Disease Week® (DDW)
VEGZELMA® (bevacizumab-adcd), YUFLYMA®(adalimumab-aaty), AVTOZMA® (tocilizumab-anho), STEQEYMA® (ustekinumab-stba), STOBOCLO® (denosumab-bmwo), OSENVELT® (denosumab-bmwo), OMLYCLO® (omalizumab-igec), and EYDENZELT® (aflibercept-boav)
More news about: Celltrion
Apr 02, 2026, 12:45 ET S&T Bancorp, Inc. to Host First Quarter Earnings Conference Call and Webcast
INDIANA, Pa., April 2, 2026 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced today that a conference call detailing the company's first quarter 2026 earnings will be held live
More news about: S&T Bancorp, Inc.
Mar 16, 2026, 08:00 ET Celltrion announces U.S. availability of AVTOZMA® (tocilizumab-anoh) subcutaneous (SC) formulation
HERZUMA® (trastuzumab-pkrb), VEGZELMA® (bevacizumab-adcd), YUFLYMA®(adalimumab-aaty), AVTOZMA® (tocilizumab-anho), STEQEYMA® (Ustekinumab-stba) STOBOCLO® (denosumab-bmwo), OSENVELT® (denosumab-bmwo), and OMLYCLO® (omalizumab-igec), as well as the novel
More news about: Celltrion
Feb 12, 2026, 10:56 ET S&T BANK LAUNCHES BRANCH REFRESH INITIATIVE TO CREATE A MORE MODERN, PEOPLE-FORWARD BANKING EXPERIENCE
Feb. 12, 2026 /PRNewswire/ -- S&T Bank, the wholly owned subsidiary of S&T Bancorp, Inc. (NASDAQ, STBA), announces the launch of a branch refresh initiative designed to reimagine its physical locations with brighter, more open spaces and a modern feel
More news about: S&T Bank
Feb 10, 2026, 10:41 ET S&T BANK NAMED A FORBES AMERICA'S BEST BANK FOR THE THIRD CONSECUTIVE YEAR
Pa., Feb. 10, 2026 /PRNewswire/ -- S&T Bank, the wholly owned subsidiary of S&T Bancorp, Inc. (NASDAQ: STBA), proudly announces that it has been named to the
More news about: S&T Bank
Jan 29, 2026, 09:18 ET S&T BANK TO OPEN NEW PITTSBURGH BRANCH AND EXPANDED OFFICE LOCATION
Jan. 29, 2026 /PRNewswire/ -- S&T Bank, the wholly owned subsidiary of S&T Bancorp, Inc. (NASDAQ, STBA), announces plans to open a new full-service branch and expanded Pittsburgh office location at One North Shore Center at 12 Federal Street, growing
More news about: S&T Bank
Jan 28, 2026, 16:35 ET S&T Bancorp, Inc. Declares Dividend
INDIANA, Pa., Jan. 28, 2026 /PRNewswire/ -- The board of directors of S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, approved a $0.36 per share cash dividend on January 28, 2026. This is an increase of $0.02, or 5.88 percent,
More news about: S&T Bancorp, Inc.
Jan 22, 2026, 07:30 ET S&T Bancorp, Inc. Announces Fourth Quarter and Full Year 2025 Results
INDIANA, Pa., Jan. 22, 2026 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced fourth quarter and full year 2025 earnings. Net income of $34.0 million, or $0.89 per diluted share,
More news about: S&T Bancorp, Inc.
Jan 22, 2026, 07:20 ET S&T Bancorp, Inc. Announces $100 Million Share Repurchase Program
INDIANA, Pa., Jan. 22, 2026 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced that the board of directors authorized a new $100 million share repurchase program at its meeting held
More news about: S&T Bancorp, Inc.
Jan 02, 2026, 11:35 ET S&T Bancorp, Inc. to Host Fourth Quarter Earnings Conference Call and Webcast
INDIANA, Pa., Jan. 2, 2026 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced today that a conference call detailing the company's fourth quarter and full year 2025 earnings will
More news about: S&T Bancorp, Inc.
Dec 02, 2025, 19:43 ET Celltrion announces U.S. FDA approval of 300mg strength of OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®
HERZUMA® (trastuzumab-pkrb), VEGZELMA® (bevacizumab-adcd), YUFLYMA®(adalimumab-aaty), AVTOZMA® (tocilizumab-anho), STEQEYMA® (ustekinumab-stba) STOBOCLO® (denosumab-bmwo), OSENVELT® (denosumab-bmwo), OMLYCLO® (omalizumab-igec), and EYDENZELT®
More news about: Celltrion
Nov 26, 2025, 01:48 ET Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal
(rituximab-abbs), HERZUMA® (trastuzumab-pkrb), VEGZELMA® (bevacizumab-adcd), YUFLYMA®(adalimumab-aaty), AVTOZMA® (tocilizumab-anho), STEQEYMA® (ustekinumab-stba), STOBOCLO® (denosumab-bmwo), OSENVELT® (denosumab-bmwo), OMLYCLO® (omalizumab-igec), and EYDENZELT® (aflibercept-boav) as well as the novel biologic
More news about: Celltrion
Oct 30, 2025, 10:07 ET S&T BANCORP WELCOMES STEPHANIE N. DOLIVEIRA TO BOARD OF DIRECTORS
INDIANA, Pa., Oct. 30, 2025 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced today that Stephanie N. Doliveira will join its board of directors. She has also been appointed as
More news about: S&T Bancorp, Inc.
Oct 30, 2025, 03:28 ET U.S. FDA grants interchangeability designation to Celltrion's denosumab biosimilars, STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo)
HERZUMA® (trastuzumab-pkrb), VEGZELMA® (bevacizumab-adcd), YUFLYMA®(adalimumab-aaty), AVTOZMA® (tocilizumab-anho), STEQEYMA® (Ustekinumab-stba) STOBOCLO® (denosumab-bmwo), OSENVELT® (denosumab-bmwo), OMLYCLO® (omalizumab-igec), and EYDENZELT®
More news about: Celltrion
Oct 29, 2025, 17:43 ET S&T Bancorp, Inc. Increases Quarterly Cash Dividend
INDIANA, Pa., Oct. 29, 2025 /PRNewswire/ -- The Board of Directors of S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, approved a $0.36 per share cash dividend on October 29, 2025. This is an increase of $0.02, or 5.88 percent,
More news about: S&T Bancorp, Inc.
Oct 23, 2025, 07:30 ET S&T Bancorp, Inc. Announces Third Quarter 2025 Results
INDIANA, Pa., Oct. 23, 2025 /PRNewswire/ -- S&T Bancorp, Inc. (S&T) (NASDAQ: STBA), the holding company for S&T Bank, announced net income of $35.0 million, or $0.91 per diluted share, for the third quarter of 2025 compared to
More news about: S&T Bancorp, Inc.
Oct 17, 2025, 01:32 ET FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States
VEGZELMA® (bevacizumab-adcd), YUFLYMA®(adalimumab-aaty), AVTOZMA® (tocilizumab-anho), STEQEYMA® (ustekinumab-stba) STOBOCLO® (denosumab-bmwo), OSENVELT® (denosumab-bmwo), OMLYCLO® (omalizumab-igec), and EYDENZELT®
More news about: Celltrion USA